Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ST 1898 - Beijing Scitech-Mq Pharmaceuticals

Next Previous
X
Search
Drug Profile

ST 1898 - Beijing Scitech-Mq Pharmaceuticals

Alternative Names: ST-1898 - Beijing Scitech-Mq Pharmaceuticals

Latest Information Update: 22 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Beijing Scitech-Mq Pharmaceuticals
  • Class Antineoplastics; Retinoids; Small molecules
  • Mechanism of Action Protein tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Thyroid cancer
  • Phase I/II Malignant melanoma; Renal cell carcinoma

Most Recent Events

  • 15 Nov 2023 Phase-II clinical trials in Thyroid cancer (Late-stage disease, Metastatic disease, Second-line or greater) (PO) in China (NCT06359847)
  • 07 Nov 2023 Phase-I/II clinical trials in Malignant melanoma (Monotherapy) in China (PO) (NCT06359860)
  • 08 May 2023 NMPA accepts IND of ST 1898 for solid tumors

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top